ARTNX
Price
$15.34
Change
-$0.43 (-2.73%)
Updated
Dec 18 closing price
VIVIX
Price
$65.90
Change
-$1.70 (-2.51%)
Updated
Dec 18 closing price
Ad is loading...

ARTNX vs VIVIX

Header iconARTNX vs VIVIX Comparison
Open Charts ARTNX vs VIVIXBanner chart's image
Artisan Select Equity Investor
Price$15.34
Change-$0.43 (-2.73%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$65.90
Change-$1.70 (-2.51%)
VolumeN/A
CapitalizationN/A
ARTNX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARTNX vs. VIVIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTNX is a StrongBuy and VIVIX is a Hold.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. ARTNX (53.7M). VIVIX pays higher dividends than ARTNX: VIVIX (2.37) vs ARTNX (0.43). ARTNX was incepted earlier than VIVIX: ARTNX (5 years) vs VIVIX (26 years). ARTNX is a more actively managed with annual turnover of: 26.63 vs. VIVIX (10.00). ARTNX has a lower initial minimum investment than VIVIX: ARTNX (1000) vs VIVIX (5000000). ARTNX annual gain was more profitable for investors over the last year : 19.93 vs. VIVIX (16.43).
ARTNXVIVIXARTNX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years26 years-
Gain YTD17.43416.034109%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets53.7M195B0%
Annual Yield % from dividends0.432.3718%
Returns for 1 year19.9316.43121%
Returns for 3 years22.7520.48111%
Returns for 5 yearsN/A44.60-
Returns for 10 yearsN/A104.87-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUOT4.530.29
+6.84%
Duos Technologies Group
APLS34.530.87
+2.58%
Apellis Pharmaceuticals
OBT59.21-0.03
-0.05%
Orange County Bancorp
FTV75.73-1.12
-1.46%
Fortive Corp
HY52.58-0.96
-1.79%
Hyster-Yale Inc.